PRODUCTION AND OPTIMIZATION METHOD OF SMART HYDROGELS BASED ON BIOCOMPATIBLE POLYMER FOR CONTROLLED INSULIN RELEASE

Year 2016, Volume: 34 Issue: 1, 115 - 122, 01.03.2016

Hediye Irem Ozgunduz Hava Gizem Kandılcı Nil Acaralı Hanifi Sarac

Abstract

The aim of controlled insulin delivery study experiments is to produce the smart hydrogel to use insulin release for human body. Insulin entrapped p(HEMA-co-Eudragit L-100) hydrogels containing different ratios of 2-Hydroxyethyl methacrylate (HEMA) and Eudragit L-100 were synthesized by using ammonium persulfate (APS) as an initiator and ethylene glycol dimethacrylate (EGDMA) as a cross linker and new alternative ways were worked on to find and develop. Taguchi method was used and optimum synthesis conditions were determined. Insulin was entrapped into hydrogels as synthesis. After entrapped method, loading efficiency values were calculated. and the hydrogels produced were characterized by using Fourier Transform Infrared Spectroscopy (FT-IR) and Scanning electron microscope (SEM) analysis.

Keywords

Hydrogel, insulin, Taguchi, Eudragit.

References

• [1] Byrne M.E., Park K., Peppas N.A., “Synthesis, Swelling and Drug Release Behavior of Poly(N,N-diethylacrylamide-co-N-hydroxymethyl acrylamide) Hydrogel”, Adv. Drug Deliver. Rev., 54(1), 149, 2002.
• [2] Zou X., Zhao X., Ye L., et al., “Preparation and Drug Release Behavior of pH-Responsive Bovine Serum Albumin-Loaded Chitosan Microspheres”, J. Ind. Eng. Chem., article in press, DOI: 10.1016/j.jiec.2014.06.012, 2014.
• [3] de Leede L.G.J., de Boer A.G., Ptirtzgen E., et al., “Rate-Controlled Rectal Drug Delivery in Man with a Hydrogel Preparation”, J. Control. Release, 4, 17, 1986.
• [4] Zhang Y., Wu X., Meng L., et al., “Thiolated Eudragit Nanoparticles for Oral Insulin Delivery: Preparation, Characterization and in Vivo Evaluation”, Int. J. Pharm., 436, 341, 2012.
• [5] Huynh D.P., Im G.J., Chae S.Y., et al., “Controlled Release of Insulin from pH/Temperature-Sensitive Injectable Pentablock Copolymer Hydrogel”, J. Control. Release, 137, 20 2009.
• [6] Chaturvedi K., Ganguly K., Nadagouda M.N., et al., “Polymeric Hydrogels for Oral Insulin Delivery”, J. Control. Release, 165, 129, 2013.
• [7] Hao S., Wang B., Wang Y., et al., “Preparation of Eudragit L 100-55 Enteric Nanoparticles by a Novel Emulsion Diffusion Method”, Colloid. Surface B, 108, 127, 2013.
• [8] Gandhi A., Jana S., Sen K.K., “In-vitro Release of Acyclovir Loaded Eudragit RLPO®Nanoparticles for Sustained Drug Delivery”, Int. J. Biol. Macromol., 67, 478, 2014.
• [9] Sadeghi M., “Synthesis and Swelling Behaviors of Graft Copolymer Based on Chitosan-g-Poly(AA-co-HEMA)”, Int. J. Chem. Eng. App., 1(4), 354, 2010.
• [10] Emileh A., Vasheghani-Farahani E., Imani M., “Swelling Behavior, Mechanical Properties and Network Parameters of pH- and Temperature Sensitive Hydrogels of Poly((2-dimethyl amino) ethyl methacrylate-co-butyl methacrylate)”, Eur. Polym. J., 43, 1986, 2007.
• [11] Raghavendra C.M., Vidhya R., Tejraj M.A., “pH-Sensitive Oral Insulin Delivery Systems Using Eudragit Microspheres”, Drug Dev. Ind. Pharm., 37(8), 977–985, 2011.
• [12] Lowman A.M., Morishita M., Kajita M., et al., “Oral Delivery of Insulin Using pH-Responsive Complexation Gels”, Journal of Pharmaceutical Sciences, 88(9), 933-937, 2000.
• [13] Kaushik G., Thakur I.S., “Isolation and Characterization of Distillery Spent Wash Color Reducing Bacteria and Process Optimization by Taguchi Approach”, Int. Biodeter. Biodegr., 63, 420, 2009.